Cargando…

Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma

BACKGROUND: Palmitoylethanolamide (PEA) is an endogenous fatty acid amide displaying anti-inflammatory and analgesic actions. Moreover, several data have suggested that PEA reduced inflammation and tissue injury associated with spinal cord trauma and showed a regulatory role for peroxisome prolifera...

Descripción completa

Detalles Bibliográficos
Autores principales: Paterniti, Irene, Impellizzeri, Daniela, Crupi, Rosalia, Morabito, Rossana, Campolo, Michela, Esposito, Emanuela, Cuzzocrea, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579707/
https://www.ncbi.nlm.nih.gov/pubmed/23374874
http://dx.doi.org/10.1186/1742-2094-10-20
_version_ 1782260147336249344
author Paterniti, Irene
Impellizzeri, Daniela
Crupi, Rosalia
Morabito, Rossana
Campolo, Michela
Esposito, Emanuela
Cuzzocrea, Salvatore
author_facet Paterniti, Irene
Impellizzeri, Daniela
Crupi, Rosalia
Morabito, Rossana
Campolo, Michela
Esposito, Emanuela
Cuzzocrea, Salvatore
author_sort Paterniti, Irene
collection PubMed
description BACKGROUND: Palmitoylethanolamide (PEA) is an endogenous fatty acid amide displaying anti-inflammatory and analgesic actions. Moreover, several data have suggested that PEA reduced inflammation and tissue injury associated with spinal cord trauma and showed a regulatory role for peroxisome proliferator-activated receptor (PPAR)-α signaling in the neuroprotective effect of PEA. However, several other mechanisms could explain the anti-inflammatory and anti-hyperalgesic effects of PEA, including the activation of PPAR-δ and PPAR-γ. The aim of the present study was to carefully investigate the exact contribution of PPAR-δ and PPAR-γ in addition to PPAR-α, in the protective effect of PEA on secondary inflammatory damage associated with an experimental model of spinal cord injury (SCI). METHODS: SCI was induced in mice through a spinal cord compression by the application of vascular clips (force of 24 g) to the dura via a four-level T5 to T8 laminectomy, and PEA (10 mg/kg, intraperitoneally, 1 and 6 hours after SCI) was injected into wildtype mice and into mice lacking PPAR-α (PPAR-αKO). To deepen the ability of specific PPAR-δ and PPAR-γ antagonists to reverse the effect of PEA, mice were administered GSK0660 or GW9662, 30 minutes before PEA injection. RESULTS: Genetic ablation of PPAR-α in mice exacerbated spinal cord damage, while PEA-induced neuroprotection seemed be abolished in PPARαKO mice. Twenty-four hours after spinal cord damage, immunohistological and biochemical studies were performed on spinal cord tissue. Our results indicate that PPAR-δ and PPAR-γ also mediated the protection induced by PEA. In particular, PEA was less effective in PPAR-αKO, GSK0660-treated or GW9662-pretreated mice, as evaluated by the degree of spinal cord inflammation and tissue injury, neutrophil infiltration, proinflammmatory cytokine, inducible nitric oxide synthase expression and motor function. PEA is also able to restore PPAR-δ and PPAR-γ expression in spinal cord tissue. CONCLUSION: This study indicates that PPAR-δ and PPAR-γ can also contribute to the anti-inflammatory activity of PEA in SCI.
format Online
Article
Text
id pubmed-3579707
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35797072013-02-23 Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma Paterniti, Irene Impellizzeri, Daniela Crupi, Rosalia Morabito, Rossana Campolo, Michela Esposito, Emanuela Cuzzocrea, Salvatore J Neuroinflammation Research BACKGROUND: Palmitoylethanolamide (PEA) is an endogenous fatty acid amide displaying anti-inflammatory and analgesic actions. Moreover, several data have suggested that PEA reduced inflammation and tissue injury associated with spinal cord trauma and showed a regulatory role for peroxisome proliferator-activated receptor (PPAR)-α signaling in the neuroprotective effect of PEA. However, several other mechanisms could explain the anti-inflammatory and anti-hyperalgesic effects of PEA, including the activation of PPAR-δ and PPAR-γ. The aim of the present study was to carefully investigate the exact contribution of PPAR-δ and PPAR-γ in addition to PPAR-α, in the protective effect of PEA on secondary inflammatory damage associated with an experimental model of spinal cord injury (SCI). METHODS: SCI was induced in mice through a spinal cord compression by the application of vascular clips (force of 24 g) to the dura via a four-level T5 to T8 laminectomy, and PEA (10 mg/kg, intraperitoneally, 1 and 6 hours after SCI) was injected into wildtype mice and into mice lacking PPAR-α (PPAR-αKO). To deepen the ability of specific PPAR-δ and PPAR-γ antagonists to reverse the effect of PEA, mice were administered GSK0660 or GW9662, 30 minutes before PEA injection. RESULTS: Genetic ablation of PPAR-α in mice exacerbated spinal cord damage, while PEA-induced neuroprotection seemed be abolished in PPARαKO mice. Twenty-four hours after spinal cord damage, immunohistological and biochemical studies were performed on spinal cord tissue. Our results indicate that PPAR-δ and PPAR-γ also mediated the protection induced by PEA. In particular, PEA was less effective in PPAR-αKO, GSK0660-treated or GW9662-pretreated mice, as evaluated by the degree of spinal cord inflammation and tissue injury, neutrophil infiltration, proinflammmatory cytokine, inducible nitric oxide synthase expression and motor function. PEA is also able to restore PPAR-δ and PPAR-γ expression in spinal cord tissue. CONCLUSION: This study indicates that PPAR-δ and PPAR-γ can also contribute to the anti-inflammatory activity of PEA in SCI. BioMed Central 2013-02-01 /pmc/articles/PMC3579707/ /pubmed/23374874 http://dx.doi.org/10.1186/1742-2094-10-20 Text en Copyright ©2013 Paterniti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Paterniti, Irene
Impellizzeri, Daniela
Crupi, Rosalia
Morabito, Rossana
Campolo, Michela
Esposito, Emanuela
Cuzzocrea, Salvatore
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title_full Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title_fullStr Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title_full_unstemmed Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title_short Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
title_sort molecular evidence for the involvement of ppar-δ and ppar-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579707/
https://www.ncbi.nlm.nih.gov/pubmed/23374874
http://dx.doi.org/10.1186/1742-2094-10-20
work_keys_str_mv AT paternitiirene molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT impellizzeridaniela molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT crupirosalia molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT morabitorossana molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT campolomichela molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT espositoemanuela molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma
AT cuzzocreasalvatore molecularevidencefortheinvolvementofppardandpparginantiinflammatoryandneuroprotectiveactivitiesofpalmitoylethanolamideafterspinalcordtrauma